These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1004640)

  • 21. Evidence that bradykinin stimulates renal prostaglandin synthesis by a mechanism distinct from that of other vasoactive substances.
    Cooper CL; Malik KU
    Circ Res; 1987 Jun; 60(6):914-22. PubMed ID: 3109763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin I, II, and II tachyphylaxis in the mesenteric vascular circuit of the rat.
    Fasciolo JC; Binia A
    Hypertension; 1981; 3(6 Pt 2):II-166-70. PubMed ID: 7028614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin-converting enzyme, bradykinin, angiotensin, and cerebral vessel reactivity.
    Whalley ET; Wahl M; Sampaio CA
    Hypertension; 1983; 5(6 Pt 3):V34-7. PubMed ID: 6317557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodynamic and metabolic effects of angiotensin II on the liver.
    Nascimento EA; Gioli-Pereira L; Carvalho LT; Santos EL; Pesquero JB; Kouyoumdjian M; Borges DR
    Peptides; 2005 Feb; 26(2):315-22. PubMed ID: 15629544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver angiotensin II receptors in the rat: binding properties and regulation by dietary Na+ and angiotensin II.
    Sernia C; Sinton L; Thomas WG; Pascoe W
    J Endocrinol; 1985 Jul; 106(1):103-11. PubMed ID: 2991407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
    Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T
    Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute changes in the renin-angiotensin system modify bradykinin and angiotensin reactivity and metabolism in conscious rats.
    Salgado MC; Krieger EM
    Hypertension; 1983; 5(6 Pt 3):V172-6. PubMed ID: 6317556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of kininase II inhibitors on the response of feline cerebral arteries to bradykinin and angiotensin.
    Whalley ET; Wahl M
    Pflugers Arch; 1983 Jul; 398(2):175-7. PubMed ID: 6312406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thimet oligopeptidase EC 3.4.24.15 is a major liver kininase.
    Molina HM; Carmona AK; Kouyoumdjian M; Borges DR
    Life Sci; 2000 Jun; 67(5):509-20. PubMed ID: 10993116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin converting activity assessed in vivo is increased in hereditary hypertensive rats.
    Krieger EM; Yamori Y; Lovenberg WM
    Braz J Med Biol Res; 1992; 25(12):1215-22. PubMed ID: 1341916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of extrapulmonary conversion in mediating the systemic pressor activity of angiotensin I.
    Oates HF; Stokes GS
    J Exp Med; 1974 Jul; 140(1):79-86. PubMed ID: 4366060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformational basis for the biological activity of TOAC-labeled angiotensin II and bradykinin: electron paramagnetic resonance, circular dichroism, and fluorescence studies.
    Schreier S; Barbosa SR; Casallanovo F; Vieira Rde F; Cilli EM; Paiva AC; Nakaie CR
    Biopolymers; 2004 Aug; 74(5):389-402. PubMed ID: 15222018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of rat pulmonary vascular aminopeptidase P in vivo: role in the inactivation of bradykinin.
    Ryan JW; Berryer P; Chung AY; Sheffy DH
    J Pharmacol Exp Ther; 1994 Jun; 269(3):941-7. PubMed ID: 8014881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local inhibition of bradykinin degradation in ischemic hearts.
    Linz W; Martorana PA; Schölkens BA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of endothelium in conversion of angiotensin I to angiotensin II in rabbit aorta.
    Saye JA; Singer HA; Peach MJ
    Hypertension; 1984; 6(2 Pt 1):216-21. PubMed ID: 6202632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of chronic oral contraceptive treatment on the conversion of angiotensin I to angiotensin II in the rat.
    Bell C; Bakhle YS
    J Pharmacol Exp Ther; 1975 Apr; 193(1):160-5. PubMed ID: 1133762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of a new aminopeptidase P inhibitor, apstatin, on bradykinin degradation in the rat lung.
    Prechel MM; Orawski AT; Maggiora LL; Simmons WH
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1136-42. PubMed ID: 8531074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kallikrein potentiation of angiotensin I-induced contraction on isolated mesenteric artery.
    Larsson-Backstrom C
    Adv Exp Med Biol; 1983; 156():445-55. PubMed ID: 6190376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endopeptidases (kininases) are able to hydrolyze kinins in tubular fluid along the rat nephron.
    Casarini DE; Boim MA; Stella RC; Schor N
    Am J Physiol; 1999 Jul; 277(1):F66-74. PubMed ID: 10409299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of hypoxia on the conversion of angiotensin I to II in the isolated perfused rat lung.
    Oparil S; Winternitz S; Gould V; Baerwaldt M; Szidon P
    Biochem Pharmacol; 1982 Apr; 31(7):1375-9. PubMed ID: 7092927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.